Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (2): 275-283.doi: 10.13481/j.1671-587X.20210204
• Research in basic medicine • Previous Articles Next Articles
Bingxue QI1,Yan MA1,Yixian ZHANG2,Yadong SUN1(),Lining MIAO2
Received:
2020-09-08
Online:
2021-03-28
Published:
2021-03-25
Contact:
Yadong SUN
E-mail:ydsun_2005@163.com
CLC Number:
Bingxue QI,Yan MA,Yixian ZHANG,Yadong SUN,Lining MIAO. Effect of liraglutide on expressions of mRNA and protein of related proteins after podocyte injury induced by high glucose and its mechanism[J].Journal of Jilin University(Medicine Edition), 2021, 47(2): 275-283.
1 | ZAVATTARO M, CAPUTO M, SAMA M T, et al. One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study[J]. Endocrine, 2015, 50(3):620-626. |
2 | DE LUCAS M D G, BUENO B A, SIERRA J O. Liraglutide preserves renal function in overweight diabetic patients with stage 3 chronic kidney disease[J]. Euro J Int Med,2017, 44:e28-e29. |
3 | KRISTENSEN S L, RØRTH R, JHUND P S, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials[J]. Lancet Diabetes Endocrinol, 2019, 7(10):776-785. |
4 | KAWANAMI D, TAKASHI Y. GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms[J]. Front Pharmacol, 2020, 11:967. |
5 | ZHANG S S, WU Z, ZHANG Z,et al. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products[J]. Biochem Biophys Res Commun, 2017, 482(4):1413-1419. |
6 | SHI J X, HUANG Q. Glucagonlike peptide1 protects mouse podocytes against high glucoseinduced apoptosis, and suppresses reactive oxygen species production and proinflammatory cytokine secretion,through sirtuin 1 activation in vitro[J]. Mol Med Rep, 2018, 18(2): 1789-1797. |
7 | CHEN P, SHI X Z,XU X, et al. Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model[J]. Diabetes Res Clin Pract, 2018, 137:173-182. |
8 | SIDDIQI F S, MAJUMDER S, THAI K, et al. The histone methyltransferase enzyme enhancer of zeste homolog 2 protects against podocyte oxidative stress and renal injury in diabetes[J]. J Am Soc Nephrol, 2016,27(7):2021-2034. |
9 | CARNEY E F. Cholesterol and podocyte injury[J]. Nat Rev Nephrol, 2013, 9(9):493-493. |
10 | TANG S C W, YIU W H. Innate immunity in diabetic kidney disease[J]. Nat Rev Nephrol, 2020,16(4):206-222. |
11 | HARALOSSON B,NYSTROÖM J,DEEN W M. Properties of the glomerular barrier and mechanisms of proteinuria[ J ]. Physiol Rev, 2008, 88(2):451-487. |
12 | SCHIFFER T A, FRIEDERICH-PERSSON M. Mitochondrial reactive oxygen species and kidney hypoxia in the development of diabetic nephropathy[J]. Front Physiol, 2017, 8:211. |
13 | UMANATH K, LEWIS J B. Update on diabetic nephropathy: core curriculum 2018[ J ]. Am J Kidney Dis, 2018, 71(6):884-895. |
14 | LI X, CHUANG PY, D’AGATI V D, et al. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys[J]. J Am Soc Nephrol, 2015, 26(10):2361-2377. |
15 | SAGAR A, ARIF E, SOLANKI A K, et al. Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function[J]. Sci Rep, 2017, 7(1):12047. |
16 | KOSTOVSKA I, TOSHESKA-TRAJKOVSKA K, LABUDOVIK D, et al. Nephrin and podocalyxin-markers for early detection of hypertensive nephropathy [J]. Atherosclerosis Suppl, 2018, 32:132. |
17 | PONCHIARDI C, MAUER M, NAJAFIAN B. Temporal profile of diabetic nephropathy pathologic changes[J]. Curr Diab Rep, 2013, 13:592-599. |
18 | IMASAWA T, OBRE E, BELLANCE N, et al. High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy[J]. Faseb J, 2017, 31(1):294-307. |
19 | WEIL E J, LEMLEY K V, MASON C C, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy[J]. Kidney Int, 2012, 82(9):1010-1017. |
20 | SHARMA R, MCDONALD T S, ENG H, et al. In vitro metabolism of the glucagon-like peptide-1 (GLP-1)-derived metabolites GLP-1(9-36)amide and GLP-1(28-36)amide in mouse and human hepatocytes[J]. Drug Metab Dispos, 2013,41(12):2148-2157. |
21 | MANN J F E, ORSTED D D, BUSE J B, et al. Liraglutide and renal outcomes in type 2 diabetes[J]. New Engl J Med, 2017, 377(22):2197-2198. |
22 | YIN W, JIANG Y, XU S, et al. Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats[J]. J Diabetes Investig, 2019, 10:613-625. |
23 | LILJEDAHL L, PEDERSEN M H, MCGUIRE J N, et al. The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome[J]. Physiol Rep, 2019, 7(4):e13994. |
24 | LI Y K, MA D X, WANG Z M, et al. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis[J]. Pharmacol Res, 2018, 131:102-111. |
25 | JIA Y, ZHENG Z J,GUAN M P,et al. Exendin-4 ameliorates high-glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells[J]. Exp Mol Med, 2018, 50(5):1-13. |
26 | MUSKIET M H A, TONNEIJCK L, SMITS M M, et al. GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes[J]. Nat Rev Nephrol, 2017, 13(4):605-628. |
27 | REN Q, YOU YU S. CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway[J]. J Recept Signal Transduct Res, 2016, 36(3):288-291. |
28 | WANG Y Y, TANG L Q, WEI W. Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway[J]. Eur J Pharmacol, 2018, 824:185-192. |
29 | 谢海平,林 帆,陈 彦,等利拉鲁肽治疗2型糖尿病合并非酒精性脂肪性肝病的研究进展[J].临床肝胆病杂志,2020,36(9):2111-2114. |
30 | 李德伦,吴玲玲,董哲毅,等.小檗碱治疗肾脏疾病研究现状[J].解放军医学杂志,2020,45(10):1092-1098. |
[1] | Xue LUAN,Guanghai YAN,Haibo LI,Bo ZHANG,Wei ZHANG,Yuanyuan HUANG. Effect of salidroside on airway inflammation in mice with asthma and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 537-544. |
[2] | Cuilan LIU,Jianjun LI,He JIANG,Jing LIU,Dan WANG,Chen LI,Di ZHAO. Effect of urolithin B on biological behaviors of human glioblastome U118 MG cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 566-574. |
[3] | Jia FENG,Haichan XU,Jian WEN,Zehua WU,Yi CHEN. Effect of betulinic acid on proliferation and apoptosis of myeloma cells by regulating JAK2/STAT3 signaling pathway and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 615-622. |
[4] | Pei GONG,Jingran LIU,Shimin ZHAO,Yuzhen WANG,Jiming XIE. Inhibitory effect of MCM10 silencing on proliferation of breast cancer MDA-MB-231 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 652-659. |
[5] | Xiaohui LI,Ziwei QU,Xin LU,Qingbin MENG,Huatao CHEN,Jun REN,Chengpei TAN. Regulatory effect of exosomes carrying miR-196b-5p derived from bone marrow mesenchymal stem cells on biological characteristics of colon cancer cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 660-668. |
[6] | Tianqi ZOU,Lin BAI,Zhengxu ZHANG,He LI,Chunmei WANG,Jinghui SUN,Jianguang CHEN,Xi CHEN,Chengyi ZHANG. Inhibitory effect of prunus tomentosa thunb total flavonoids on skin hypertrophic scar in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 265-274. |
[7] | Zhanqi ZHAO,Chengjin ZHANG,Juan TIAN. Inhibitory effect of Ndfip1 on ferrion-induced neuronal apoptosis and its neuroprotective mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 338-343. |
[8] | Haoxuan TANG,Nanfeng MENG,Meiling DU,Wei WANG,Tao HE. Inhibitory effect of new VEGF monoclonal antibody combined with all-trans retinoic acid on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 344-351. |
[9] | Nuan WANG,Lijuan YANG,Juanjuan DAI,Aili WANG,Yan WU,Chengxia LIU. Promotion effects of MARCH1 on migration and invasion of human gastric cancer cells through PI3K/AKT signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 352-359. |
[10] | Jie WU,Xuehua YANG,Ling MA,Wenqiang FAN,Dongdong FU,Xiao GAO,Shufei ZUO,Shu LIANG,Yilu QIN,Peishan WANG,Jinyan GUO. Effect of miR-26a-5p on apoptosis of human rheumatoid arthritis fibroblast-like synovial cells through JAK2/STAT3 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 460-468. |
[11] | Haiying ZHANG,Wenxin ZHANG,Wenjing ZHAO,Wei LI. Induction effect of gallic acid on apoptosis of human hepatocellular carcinoma HepG-2 cells through regulating mitochondrial oxidative phosphorylation [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 125-132. |
[12] | . Inhibitory effect of curcumin on tumor growth in colorectal cancer mice and its mechanism of PTEN/PI3K/Akt signaling pathwayPEI Yongbin, WANG Guiqi, LI Wei, JIANG Xia, JIANG Haibo, ZHAO Zengren (Department of General Surgery,First Hospital,Hebei Medical University, Shijiazhuang 050031,China) [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 145-151. |
[13] | Meijuan LU,Xiande MA,Lu REN. Effect of acupuncture combined with medicine-induced autophagy on cognitive function of mice with ApoE gene knockout [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1124-1130. |
[14] | LI Qi, XU Rui, LI Tengteng, JIANG Yichuan, LI Min. Effect of pirarubicin on cardiomyocyte injury in rats and establishment of its model [J]. Journal of Jilin University(Medicine Edition), 2020, 46(05): 948-954. |
[15] | LI Wei, ZHANG Haifeng, WANG Miao, HUO Jing, ZHANG Ying, ZHAO Cui. Protective effect of Astragalus Injection on heart of rats with sleep deprivation and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(05): 998-1003. |